Strs Ohio Athenex, Inc. Transaction History

Strs Ohio

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$0.41 - $0.91 $239,481 - $531,531	-584,100 Closed	0 $0
Q1 2022 Apr 21, 2022	BUY	$0.79 - $1.59 $77,736 - $156,456	98,400 Added 20.26%	584,100 $484,000
Q4 2021 Jan 24, 2022	BUY	$1.36 - $2.94 $432,208 - $934,332	317,800 Added 189.28%	485,700 $660,000
Q2 2021 Jul 26, 2021	BUY	$3.71 - $5.13 $622,909 - $861,327	167,900 New	167,900 $775,000
Q2 2019 Jul 25, 2019	SELL	$9.44 - $19.8 $298,304 - $625,680	-31,600 Closed	0 $0
Q1 2019 Apr 19, 2019	SELL	$11.11 - $13.49 $131,098 - $159,182	-11,800 Reduced 27.19%	31,600 $387,000
Q2 2018 Aug 06, 2018	BUY	$15.88 - $19.5 $61,932 - $76,050	3,900 Added 9.87%	43,400 $809,000
Q4 2017 Jan 23, 2018	BUY	$14.41 - $19.15 $540,375 - $718,125	37,500 Added 1875.0%	39,500 $628,000
Q3 2017 Oct 23, 2017	BUY	$13.5 - $19.51 $27,000 - $39,020	2,000	2,000 $35,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.